Clinical Guidance

HeliconHeart uniquely integrates clinical guidance and advisory systems with a wide range of patient management tools. This helps clinicians to make treatment decisions faster and more efficiently.

How do we support the management of atrial fibrillation?

  • Clinical decision support for rate and rhythm control, including medication choices
  • Guidance to aid the recognition of high-risk patients with atrial fibrillation (AF)
  • Tools and advisory system to help clinicians determine who should be offered oral anticoagulation
  • Advice about the best oral anticoagulant to meet the individual patient’s needs
  • Tools to support the management of other risk factors and co-morbidities associated with atrial fibrillation (AF) e.g hypertension and coronary artery disease.

 

What does our anticoagulation advisory system include?

  • Trial validated algorithms for anticoagulation dosing and monitoring intervals
  • Anticoagulant plan management
  • Tools to improve the time spent in the therapeutic range and thus reduce the likelihood of stroke
  • Automatic calculation of stroke risk score
  • Alerts for adverse events
  • Advisory and monitoring system for new oral anticoagulant drugs e.g. dabigatran, rivaroxaban and apixaban.